Browse by author
Lookup NU author(s): Professor Giorgio TascaORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons LtdMutations in KARS, which encodes for both mitochondrial and cytoplasmic lysyl-tRNA synthetase, have been so far associated with three different phenotypes: the recessive form of Charcot–Mary–Tooth polyneuropathy, the autosomal recessive nonsyndromic hearing loss and the last recently described condition related to congenital visual impairment and progressive microcephaly. Here we report the case of a 14-year-old girl with severe cardiomyopathy associated to mild psychomotor delay and mild myopathy; moreover, a diffuse reduction of cytochrome C oxidase (COX, complex IV) and a combined enzymatic defect of complex I (CI) and complex IV (CIV) was evident in muscle biopsy. Using the TruSight One sequencing panel we identified two novel mutations in KARS. Both mutations, never reported previously, occur in a highly conserved region of the catalytic domain and displayed a dramatic effect on KARS stability. Structural analysis confirmed the pathogenic role of the identified variants. Our findings confirm and emphasize that mt-aminoacyl-tRNA synthetases (mt-ARSs) enzymes are related to a broad clinical spectrum due to their multiple and still unknown functions.
Author(s): Verrigni D, Diodato D, Di Nottia M, Torraco A, Bellacchio E, Rizza T, Tozzi G, Verardo M, Piemonte F, Tasca G, D'Amico A, Bertini E, Carrozzo R
Publication type: Article
Publication status: Published
Journal: Clinical Genetics
Year: 2017
Volume: 91
Issue: 6
Pages: 918-923
Print publication date: 01/06/2017
Online publication date: 28/11/2016
Acceptance date: 23/11/2016
ISSN (print): 0009-9163
ISSN (electronic): 1399-0004
Publisher: Blackwell Publishing Ltd
URL: https://doi.org/10.1111/cge.12931
DOI: 10.1111/cge.12931
PubMed id: 27891585
Altmetrics provided by Altmetric
